Effects of rs769217 and rs1001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus

Free Radical Research

Volumn 46, Issue 10, 2012, Pages 1249-1257

  Góth, László ^a   Nagy, Teréz ^a   Kósa, Zsuzsanna ^a   Fejes, Zsolt ^a   Bhattoa, Harjit Pal ^b   Paragh, György ^b   Káplár, Miklós ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Catalase gene; Catalase polymorphisms; Decreased catalase; Diabetes mellitus; Hydrogen peroxide; Reactive oxygen species

Indexed keywords

APOLIPOPROTEIN B; CARBOHYDRATE; CATALASE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CARBOHYDRATE METABOLISM; CARBOHYDRATES; CASE-CONTROL STUDIES; CATALASE; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 84866315139     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.702899     Document Type: Article

References (54)

1. Ahlqvist E, Ahluwalia TS, Groop L. Genetics of type 2 diabetes . Clin Chem 2011; 57: 241-254.
2. Geth L, Nagy T. Acatalasemia and diabetes. Arch Biochem Biophys, in press. doi:10.1016/j.abb.201202.005.
3. Forsberg L, de Faire U, Mergenstern R. Oxidative stress, human gene variations, and disease. Arch Biochem Biophys 2001; 389: 87-93.
4. Robertson PR. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2007; 212: 167-178.
5. Minni M, Chen Q, Bartol K, Perkin PK-A, Reuter B, Young L. The real-time measurement of blood nitric oxide (NO) and hydrogen peroxide (H 2 O 2) levels under acute hyperglycemia. FASEB J 2011: 25 (Marc 17 821.21).
6. Veal E, Day A. Hydrogen peroxide as a signaling molecule. Antiox Redox Signal 2011; 15: 147-151.
7. Mueller S, Riedel HD, Stremmel W. Direct evidence for catalase as the predominant H 2 O 2 removing enzyme in erythrocytes . Blood 1997; 90: 4973-4978. (Pubitemid 28007213)
8. Vitai M, Geth L. Reference ranges of normal blood catalase activity and levels in familial hypocatalasemia. Clin Chim Acta 1997; 261: 35-42.
9. Geth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991; 191: 143-151.
10. Olafsson T, Olafsson I. Purifi cation of human granulocyte catalase in chronic leukemia. Bichem Biophys Acta 1977; 482: 301-308.
11. Seghieri G, Simplicio P, Aninchini R, Alvigi L, De Bellis A, Bennardini F, Fanconi F. Platelet antioxidant enzymes in insulin dependent diabetes mellitus. Clin Chim Acta 2001; 309: 19-23. (Pubitemid 32530734)
12. Gaetani GF, Ferraris AM, Rolfo M, Mangerini R, Arena S, Kirkman HV. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood 1996; 87: 1595-1599. (Pubitemid 26056926)
13. Masuoka N, Wakimoto M, Ubuka T, Nakano T. Spectrophotometric determination of hydrogen peroxide: catalase activity and rates of hydrogen peroxide removal by erythrocytes. Clin Chim Acta 1996; 254: 101-112. (Pubitemid 26325560)
14. Masuoka N, Kodama H, Abe T, Wang DH, Nakano T. Characterization of hydrogen peroxide removal reaction by hemoglobin in the presence of reduced pyridine nucleotides. BBA Mol Base Dis 2003; 1637: 46-54. (Pubitemid 36071595)
15. Kirkman HN, Gaetani GF. Mammalian catalase: a venerable enzyme with new mysteries. Trends Biomed Sci 2007; 32: 144-160.
16. Takemoto K, Tanaka M, Nishihara R, Ishihara K, Wang D-H, Ogino K, Taniuchi K, Masuoka N. Low catalase activity in blood is associated with the diabetes caused by alloxan. Clin Chim Acta 2009; 407: 43-46.
17. Kikumoto Y, Sugiyama H, Inoue T, Morinaga H, Takiue K, Kitagawa M, et al. Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice. BBA Mol Base Dis 2010; 1802: 240-246.
18. Geth L, Eaton JW. Hereditary catalase defi ciencies and increased risk of diabetes. Lancet 2000; 356: 1820-1821.
19. Geth L. Catalase defi ciency and type 2 diabetes. Diab Care 2008; 31: e93.
20. Hur J, Sullivan KA, Schuyler AD, Hong Y, Pande M, States DJ, Jagadish HV, Feldman EI. Literature-based discovery of diabetes-and ROS-related targets. BMC Med Genomics 2010; 3: 49-60.
21. Wen JK, Osumi T, Hashimoto T. Molecular analysis of human acatalasemia. J Mol Biol 1990; 211: 383-393.
22. Kishimoto Y, Murakami Y, Hayashi K, Takahara S, Sigumara T, Sekiya T. Detection of a common mutation of the catalase gene in Japanese acatalasemic patients. Hum Genet 1992; 88: 487-490.
23. Casp CB, She J, McCormack WT. Genetic association of catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002; 15: 62-66. (Pubitemid 34535975)
24. Gavalas NG, Akhtar S, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH. Analysis of allelic variants in the catalase gene in patients with the skin depigmentation disorder vitiligo. Biochem Biophys Res Comm 2006; 345: 1586-1591. (Pubitemid 43817910)
25. Park HH, Ha E, Uhm YK, Jin SY, Chung JH, Lee MH. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population. Exper Dermatol 2006; 15: 377-380. (Pubitemid 44056485)
26. Shajil EM, Laddha C, Chatterjee S, Gani AR, Malek RA, Shah BJ, Begum R. Association of catalase T/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population. Pigment Cell Res 2006; 20: 405-407. (Pubitemid 47390120)
27. Charmary JV, Parmley JL, Hurst LD. Hearing silence: nonneutral evolution at synonymous sites in mammals. Nature Rev Genet 2006; 7: 98-108. (Pubitemid 43128905)
28. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGMdependent xenophagy in Crohn ' s disease. Nature Genet 2011; 43: 242-245.
29. Hurs DL. The sound of silence. Nature 2011; 471: 582-583.
30. Konings A, Van Laer L, Pawelczyk M, Carlsson PI, Bondeson ML, Rajkowska E, et al. Association between variations in CAT and noise-induced hearing loss in two independent noiseexposed populations. Hum Mol Genet 2007; 16: 1872-1883. (Pubitemid 47244535)
31. Oh B, Kim SY, Kim DY, Lee YJ, Lee JK, Kimm K, et al. Association of catalase gene polymorphism with bone mineral density and bone turnover markers in postmenopausal women. J Med Genet 2007; 44: e62.
32. Tarnai I, Csords M, Sakei E, Shemirani AH, Kaplr M, Geth L. Eff ect of C111T polymorphism in exon 9 of the catalase gene on blood catalase activity in diff erent types of diabetes mellitus. Free Radic Res 2007; 41: 806-811. (Pubitemid 46995262)
33. Forsberg L, Lyrenas L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene infl uences transcription factor binding reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30: 500-505. (Pubitemid 32162956)
34. Chistiakov DA, Savostanov KV, Turakulov RI, Titovich EV, Zilberman LI, Kuraeva TL, IDedov II, Nosikov VV. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome11p13) in a Russian population. Diabet Metab Res Rev 2004; 20: 219-224. (Pubitemid 38714320)
35. Pask R, Cooper JD, Walker NM, Nutland S, Hutshings J, Dunger DB, Nejentsev S, Todd JA. No evidence for a major eff ect of two common polymorphisms of the catalase gene in type 1 diabetes susceptibility. Diabet Metab Res Rev 2006; 22: 356-360. (Pubitemid 44446430)
36. Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jaromlimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet 2008; 9: 30.
37. Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KEP, Roisenberg I. The catalase 262C/T polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis Markers 2006; 22: 355-359. (Pubitemid 46333636)
38. Letonja M, Nikolajevic-Strcevitc J, Letonja MS. Association of the 262C/T polymorphism in the catalase gene promoter with carotid atherosclerosis in Slovenian patients with type 2 diabetes. Cent Eur J Med 2011; 6: 463-469.
39. Nadif R, Mintz M, Jedlicka A, Bertrand JP, Kleeberger SR, Kauff mann F. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res 2005; 39: 1345-1350. (Pubitemid 43023799)
40. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. Association between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Amer J Epidemiol 2005; 162: 943-952. (Pubitemid 41619465)
41. Bastaki M, Huen K, Manzanillo P, Chande HN, Chen C, Balmes JR, Tager IB, Holland N. Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharamcogen Genom 2006; 16: 279-286.
42. Perianyagam MC, Liangos O, Kolyda AY, Wald R, MacKinnon RW, Li L, et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 255-263. (Pubitemid 46053437)
43. Mak JCW, Leung HCM, Ho SP, Cheung AHK, Ip MS, Chan-Yeung MMW. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exper Allergy 2006; 36: 440-447.
44. Liang B, Zhang A-H, Xi X-G, Zhang B-X, Huang X-X. Relationship between myeloperoxidase and catalase genetic polymorphisms and their activities with arsenic poisoning caused by coal-burning. Chin J Endemiol 2009; 28: 272-275.
45. Haliwell B. Antioxidants and human disease: a general introduction . Nutr Rev 1997; 55: S44-S52.
46. Ramamrishna V, Jailkhani R. Oxidative stress in non-insulindependent diabetes mellitus(NIDDM) patients. Acta Diabetol 2008; 45: 41-46. (Pubitemid 351238275)
47. Korytina GF, Akhmadishina LZ, Citousova OS, Zagidullin SZ, Victorova TV. Polymorphism of the genes for antioxidant defense enzymes and their association with the development of chronic obstructive pulmonary disease in the population of Bashkortostan. Russian J Gen 2009; 45: 848-856.
48. Szelestei T, Bahrng S, Wagner Z, Aydin A, Molnar GA, Kocsis B, Nagy J, Wittmann I. Serum levels of L-arginine analogues and glutathione peroxidase and catalase gene variants in Type 2 diabetes mellitus patients. Diabetic Med 2005; 22: 353-357.
49. Geth L. Two cases of acatalasemia in Hungary. Clin Chim Acta 1992; 207: 155-158.
50. Geth L, Lenkey A, Bigler WN. Blood catalase defi ciency and diabetes in Hungary. Diab Care 2001; 24: 1839-1840.
51. Geth L, Rass P, Pay A. Catalase enzyme mutations and their association with diseases. Mol Diag 2004; 8: 141-149. (Pubitemid 40468779)
52. Scott MD. H2O2 injury in beta-thalassemic erythrocytes: protective role of catalase and prooxidant eff ect of GSH. Free Radic Biol Med 2006; 40: 1264-1272.
53. Geth L, Teth Z, Tarnai I, Barces M, Tarek P, Bigler WN. Blood catalase activity in gestational diabetes is decreased but not associated with pregnancy complications. Clin Chem 2005; 51: 2401-2404. (Pubitemid 41692598)
54. Daferera N, Kokkas V, Goulas A. An association study between catalase 262CT gene polymorphism, sodium-lithium counter transport activity, insulin resistance, blood lipid parameters and their response to atorvastin, in Greek dyslipidaemic and normolipidaemic controls. Free Rad Res 2009; 43: 385-389.